Literature DB >> 29188433

Deciding wisely: A case for an effective use of myocardial perfusion imaging.

Rami Doukky1,2.   

Abstract

There is a vast body of literature supporting the use of stress myocardial perfusion imaging (MPI) in patients with known or suspected coronary artery disease. When applied in the appropriate clinical setting, MPI can aid, not only in diagnosis and risk stratification, but also in decision-making. In a case of a 58-year-old man with suspected coronary artery disease, we highlight how the appropriate use of stress MPI can leverage the diagnostic and prognostic utility of MPI in an effective, evidence-based decision-making aimed to achieve the best patient outcome.

Entities:  

Keywords:  Decision-making; Diagnosis; Myocardial perfusion imaging; Prognosis; SPECT

Mesh:

Year:  2017        PMID: 29188433     DOI: 10.1007/s12350-017-1136-0

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  24 in total

1.  ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines).

Authors:  Raymond J Gibbons; Gary J Balady; J Timothy Bricker; Bernard R Chaitman; Gerald F Fletcher; Victor F Froelicher; Daniel B Mark; Ben D McCallister; Aryan N Mooss; Michael G O'Reilly; William L Winters; Raymond J Gibbons; Elliott M Antman; Joseph S Alpert; David P Faxon; Valentin Fuster; Gabriel Gregoratos; Loren F Hiratzka; Alice K Jacobs; Richard O Russell; Sidney C Smith
Journal:  J Am Coll Cardiol       Date:  2002-10-16       Impact factor: 24.094

Review 2.  Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making.

Authors:  K Lance Gould; Nils P Johnson; Timothy M Bateman; Rob S Beanlands; Frank M Bengel; Robert Bober; Paolo G Camici; Manuel D Cerqueira; Benjamin J W Chow; Marcelo F Di Carli; Sharmila Dorbala; Henry Gewirtz; Robert J Gropler; Philipp A Kaufmann; Paul Knaapen; Juhani Knuuti; Michael E Merhige; K Peter Rentrop; Terrence D Ruddy; Heinrich R Schelbert; Thomas H Schindler; Markus Schwaiger; Stefano Sdringola; John Vitarello; Kim A Williams; Donald Gordon; Vasken Dilsizian; Jagat Narula
Journal:  J Am Coll Cardiol       Date:  2013-08-28       Impact factor: 24.094

3.  Postischemic stunning can affect left ventricular ejection fraction and regional wall motion on post-stress gated sestamibi tomograms.

Authors:  L L Johnson; S A Verdesca; W Y Aude; R C Xavier; L T Nott; M W Campanella; G Germano
Journal:  J Am Coll Cardiol       Date:  1997-12       Impact factor: 24.094

4.  Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial.

Authors:  Friedrich W Mohr; Marie-Claude Morice; A Pieter Kappetein; Ted E Feldman; Elisabeth Ståhle; Antonio Colombo; Michael J Mack; David R Holmes; Marie-angèle Morel; Nic Van Dyck; Vicki M Houle; Keith D Dawkins; Patrick W Serruys
Journal:  Lancet       Date:  2013-02-23       Impact factor: 79.321

Review 5.  2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.

Authors:  Stephan D Fihn; James C Blankenship; Karen P Alexander; John A Bittl; John G Byrne; Barbara J Fletcher; Gregg C Fonarow; Richard A Lange; Glenn N Levine; Thomas M Maddox; Srihari S Naidu; E Magnus Ohman; Peter K Smith
Journal:  J Am Coll Cardiol       Date:  2014-07-28       Impact factor: 24.094

6.  Overestimation of postischemic myocardial stunning on gated SPECT imaging: correlation with echocardiography.

Authors:  R Parker Ward; Ethan L Gundeck; Roberto M Lang; Kirk T Spencer; Kim A Williams
Journal:  J Nucl Cardiol       Date:  2006-07       Impact factor: 5.952

7.  Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease.

Authors:  G A Diamond; J S Forrester
Journal:  N Engl J Med       Date:  1979-06-14       Impact factor: 91.245

8.  Value of exercise treadmill testing in women.

Authors:  K P Alexander; L J Shaw; L K Shaw; E R Delong; D B Mark; E D Peterson
Journal:  J Am Coll Cardiol       Date:  1998-11-15       Impact factor: 24.094

9.  Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.

Authors:  Leslee J Shaw; Daniel S Berman; David J Maron; G B John Mancini; Sean W Hayes; Pamela M Hartigan; William S Weintraub; Robert A O'Rourke; Marcin Dada; John A Spertus; Bernard R Chaitman; John Friedman; Piotr Slomka; Gary V Heller; Guido Germano; Gilbert Gosselin; Peter Berger; William J Kostuk; Ronald G Schwartz; Merill Knudtson; Emir Veledar; Eric R Bates; Benjamin McCallister; Koon K Teo; William E Boden
Journal:  Circulation       Date:  2008-02-11       Impact factor: 29.690

10.  Economic Outcomes With Anatomical Versus Functional Diagnostic Testing for Coronary Artery Disease.

Authors:  Daniel B Mark; Jerome J Federspiel; Patricia A Cowper; Kevin J Anstrom; Udo Hoffmann; Manesh R Patel; Linda Davidson-Ray; Melanie R Daniels; Lawton S Cooper; J David Knight; Kerry L Lee; Pamela S Douglas
Journal:  Ann Intern Med       Date:  2016-05-24       Impact factor: 25.391

View more
  1 in total

1.  Case Presentation Commentary on "Deciding wisely: A case for an effective use of myocardial perfusion imaging".

Authors:  Lawrence Phillips
Journal:  J Nucl Cardiol       Date:  2017-12-07       Impact factor: 5.952

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.